PL2079727T3 - Inhibitory kinazy - Google Patents
Inhibitory kinazyInfo
- Publication number
- PL2079727T3 PL2079727T3 PL07838410T PL07838410T PL2079727T3 PL 2079727 T3 PL2079727 T3 PL 2079727T3 PL 07838410 T PL07838410 T PL 07838410T PL 07838410 T PL07838410 T PL 07838410T PL 2079727 T3 PL2079727 T3 PL 2079727T3
- Authority
- PL
- Poland
- Prior art keywords
- kinase inhibitor
- inhibitor compounds
- compounds
- kinase
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84490206P | 2006-09-15 | 2006-09-15 | |
EP07838410.4A EP2079727B1 (en) | 2006-09-15 | 2007-09-14 | Kinase inhibitor compounds |
PCT/US2007/020193 WO2008033562A2 (en) | 2006-09-15 | 2007-09-14 | Kinase inhibitor compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2079727T3 true PL2079727T3 (pl) | 2016-08-31 |
Family
ID=39184421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07838410T PL2079727T3 (pl) | 2006-09-15 | 2007-09-14 | Inhibitory kinazy |
Country Status (11)
Country | Link |
---|---|
US (4) | US7683057B2 (pl) |
EP (1) | EP2079727B1 (pl) |
JP (1) | JP5568304B2 (pl) |
KR (1) | KR101507375B1 (pl) |
CN (1) | CN101553482B (pl) |
AU (1) | AU2007294686B2 (pl) |
CA (1) | CA2662902C (pl) |
ES (1) | ES2565683T3 (pl) |
HK (1) | HK1133641A1 (pl) |
PL (1) | PL2079727T3 (pl) |
WO (1) | WO2008033562A2 (pl) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007294686B2 (en) * | 2006-09-15 | 2013-10-31 | Equinox Sciences, Llc | Kinase inhibitor compounds |
WO2009140928A1 (zh) * | 2008-05-23 | 2009-11-26 | 上海医药工业研究院 | 二氢吲哚酮衍生物 |
CN102666485A (zh) * | 2009-09-21 | 2012-09-12 | 霍夫曼-拉罗奇有限公司 | 烯烃羟吲哚衍生物及其用于治疗肥胖症,糖尿病和高脂血症的应用 |
WO2011032320A1 (en) * | 2009-09-21 | 2011-03-24 | F. Hoffmann-La Roche Ag | Novel alkene oxindole derivatives |
TWI487486B (zh) | 2009-12-01 | 2015-06-11 | Syngenta Participations Ag | 以異唑啉衍生物為主之殺蟲化合物 |
CN102858739A (zh) | 2010-03-10 | 2013-01-02 | 斯索恩有限公司 | 酰胺化吡咯甲酸酯化合物的方法 |
WO2011146336A1 (en) | 2010-05-20 | 2011-11-24 | Array Biopharma Inc. | Macrocyclic compounds as trk kinase inhibitors |
CN102115469A (zh) * | 2011-03-21 | 2011-07-06 | 浙江大学 | 吲哚啉-2-酮类衍生物的制备和用途 |
US8791112B2 (en) | 2011-03-30 | 2014-07-29 | Arrien Pharmaceuticals Llc | Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors |
TW201311677A (zh) | 2011-05-31 | 2013-03-16 | Syngenta Participations Ag | 殺蟲化合物 |
CN102295594B (zh) * | 2011-07-12 | 2016-01-20 | 上海医药工业研究院 | 4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用 |
RU2673064C2 (ru) | 2011-09-01 | 2018-11-22 | Ф. Хоффманн-Ля Рош Аг | Пирролопиразиновые ингибиторы киназы |
AR091023A1 (es) * | 2012-05-11 | 2014-12-30 | Abbvie Inc | Inhibidores del nampt |
WO2014031445A1 (en) * | 2012-08-22 | 2014-02-27 | Merck Sharp & Dohme Corp. | Novel benzimidazole tetrahydropyran derivatives |
WO2014180908A1 (en) * | 2013-05-08 | 2014-11-13 | Deutsches Krebsforschungszentrum | Acip/peptide-based inhibition of cancer cachexia |
EP3085700B1 (en) * | 2013-12-20 | 2018-10-31 | Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | Novel piperidine carboxamide compound, preparation method, and usage thereof |
CN104829596B (zh) * | 2014-02-10 | 2017-02-01 | 石家庄以岭药业股份有限公司 | 吡咯取代吲哚酮类衍生物、其制备方法、包含该衍生物的组合物、及其用途 |
MA40581A (fr) * | 2014-09-10 | 2019-04-10 | Glaxosmithkline Ip Dev Ltd | Dérivés pyridone utilisés comme inhibiteurs de la kinase réarrangée au cours de la transfection (ret) |
CN104341374A (zh) * | 2014-11-11 | 2015-02-11 | 联化科技(德州)有限公司 | 一种吗啉碳酰氯类化合物的制备方法 |
TN2018000027A1 (en) | 2015-07-16 | 2019-07-08 | Array Biopharma Inc | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors |
CN105622680B (zh) * | 2015-12-22 | 2018-01-19 | 杭州卢普生物科技有限公司 | 一种舒尼替尼衍生物及其制备方法和应用 |
CN106928114B (zh) * | 2015-12-31 | 2020-07-28 | 韶远科技(上海)有限公司 | 含有脲基的环状手性氨基类化合物及其可放大工艺和用途 |
BR112019006023A2 (pt) * | 2016-09-29 | 2019-06-18 | Equinox Sciences Llc | forma cristalina, métodos de preparação da forma cristalina e do composto, composição farmacêutica, e, métodos para tratar ou prevenir uma doença ou enfermidade e para modular atividade de cinase. |
JOP20190077A1 (ar) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret |
TWI704148B (zh) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
CN110267960B (zh) | 2017-01-18 | 2022-04-26 | 阿雷生物药品公司 | 作为RET激酶抑制剂的取代的吡唑并[1,5-a]吡嗪化合物 |
WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
TWI812649B (zh) | 2017-10-10 | 2023-08-21 | 美商絡速藥業公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物 |
TWI791053B (zh) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
CN108191835A (zh) * | 2018-01-09 | 2018-06-22 | 中国药科大学 | 一类新型的含吡咯环和吲哚啉结构rip1激酶抑制剂及其用途 |
CN111615514B (zh) | 2018-01-18 | 2022-10-11 | 奥瑞生物药品公司 | 作为ret激酶抑制剂的取代的吡唑并[4,3-c]吡啶化合物 |
TW201938169A (zh) | 2018-01-18 | 2019-10-01 | 美商亞雷生物製藥股份有限公司 | 作為RET激酶抑制劑之經取代吡唑并[3,4-d]嘧啶化合物 |
WO2019143977A1 (en) | 2018-01-18 | 2019-07-25 | Array Biopharma Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
US10589264B2 (en) * | 2018-08-10 | 2020-03-17 | Uop Llc | Processes for controlling the partial regeneration of spent catalyst from an MTO reaction |
ES2922314T3 (es) | 2018-09-10 | 2022-09-13 | Array Biopharma Inc | Compuestos heterocíclicos condensados como inhibidores de cinasa RET |
MX2021012105A (es) | 2019-04-03 | 2021-11-03 | Aligos Therapeutics Inc | Compuestos de pirrol. |
US20220289707A1 (en) * | 2019-07-03 | 2022-09-15 | The Regents Of The University Of Colorado, A Body Corporate | Amp-activated protein kinase inhibitors and methods of making and using the same |
EP4065576A1 (en) * | 2019-11-27 | 2022-10-05 | Captor Therapeutics S.A. | Piperidine-2, 6-dione derivatives which bind to cereblon, and methods of use thereof |
BR112022018815A2 (pt) | 2020-03-25 | 2022-11-29 | Ocular Therapeutix Inc | Implante ocular contendo um inibidor de tirosina cinase |
WO2022006412A2 (en) * | 2020-07-02 | 2022-01-06 | The Regents Of The University Of Colorado, A Body Corporate | Conjugates of ampk inhibitors and protac degraders and related uses |
WO2023173088A1 (en) | 2022-03-11 | 2023-09-14 | EyePoint Pharmaceuticals, Inc. | Method of preventing age-related macular degeneration by administering an ocular drug delivery insert |
TW202345804A (zh) | 2022-03-11 | 2023-12-01 | 美商視點製藥有限公司 | 治療濕性老年黃斑部病變(Wet Age-related Macular Degeneration)之方法 |
TW202400143A (zh) | 2022-03-11 | 2024-01-01 | 美商視點製藥有限公司 | 用於治療眼睛病況之持續給藥方案 |
WO2024033374A1 (en) | 2022-08-11 | 2024-02-15 | Syngenta Crop Protection Ag | Novel arylcarboxamide or arylthioamide compounds |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR034118A1 (es) | 2000-02-15 | 2004-02-04 | Sugen Inc | Compuestos de 2-indolinonas sustituidas con pirroles inhibidoras de proteinquinasas; sus composiciones farmaceuticas e intermediarios de sintesis |
CA2414468A1 (en) * | 2000-06-30 | 2002-01-10 | Sugen, Inc. | 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
EP1349852A2 (en) * | 2000-12-20 | 2003-10-08 | Sugen, Inc. | 4-(hetero)aryl substituted indolinones |
AR042586A1 (es) | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
US6599902B2 (en) * | 2001-05-30 | 2003-07-29 | Sugen, Inc. | 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors |
CA2462950A1 (en) | 2001-10-10 | 2003-04-17 | Sugen, Inc. | 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
CA2541460A1 (en) | 2003-10-24 | 2005-05-06 | Schering Aktiengesellschaft | Indolinone derivatives and their use in treating disease-states such as cancer |
CA2547066A1 (en) | 2003-11-26 | 2005-06-16 | The Scripps Research Institute | Advanced indolinone based protein kinase inhibitors |
EP1696906A1 (en) | 2003-12-16 | 2006-09-06 | Leo Pharma A/S | Novel therapeutic use of indolinone derivatives |
GT200500321A (es) * | 2004-11-09 | 2006-09-04 | Compuestos y composiciones como inhibidores de proteina kinase. | |
BRPI0611419A2 (pt) | 2005-05-26 | 2010-09-08 | Scripps Research Inst | composto, sal, tautÈmero ou pró-fármaco, método para a modulação da atividade catalìtica de uma proteìna cinase e processo para a sìntese de uma pirrolil-indolinona |
CN101282965A (zh) | 2005-09-22 | 2008-10-08 | 斯克利普斯研究院 | 基于烷氧基吲哚酮的蛋白激酶抑制剂 |
CN101389331A (zh) | 2005-12-29 | 2009-03-18 | 斯克里普斯研究学院 | 基于吲哚满酮的氨基酸衍生物的蛋白激酶抑制剂 |
CN101007801A (zh) | 2006-01-27 | 2007-08-01 | 上海恒瑞医药有限公司 | 吡咯取代的2-二氢吲哚酮衍生物、其制法与医药上的用途 |
AU2007296740B2 (en) | 2006-09-11 | 2012-09-27 | Curis, Inc. | Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety |
CN101535254A (zh) * | 2006-09-11 | 2009-09-16 | 柯瑞斯公司 | 包含锌-结合基团的取代的2-二氢吲哚酮作为ptk抑制剂 |
AU2007296744A1 (en) | 2006-09-11 | 2008-03-20 | Curis, Inc. | Multi-functional small molecules as anti-proliferative agents |
AU2007294686B2 (en) * | 2006-09-15 | 2013-10-31 | Equinox Sciences, Llc | Kinase inhibitor compounds |
-
2007
- 2007-09-14 AU AU2007294686A patent/AU2007294686B2/en active Active
- 2007-09-14 PL PL07838410T patent/PL2079727T3/pl unknown
- 2007-09-14 WO PCT/US2007/020193 patent/WO2008033562A2/en active Application Filing
- 2007-09-14 EP EP07838410.4A patent/EP2079727B1/en active Active
- 2007-09-14 CA CA2662902A patent/CA2662902C/en active Active
- 2007-09-14 ES ES07838410.4T patent/ES2565683T3/es active Active
- 2007-09-14 KR KR1020097007660A patent/KR101507375B1/ko active IP Right Grant
- 2007-09-14 CN CN2007800421920A patent/CN101553482B/zh active Active
- 2007-09-14 JP JP2009528335A patent/JP5568304B2/ja active Active
- 2007-12-28 US US12/005,872 patent/US7683057B2/en active Active
-
2010
- 2010-01-22 HK HK10100700.9A patent/HK1133641A1/zh unknown
- 2010-01-28 US US12/657,887 patent/US8039470B2/en active Active
-
2011
- 2011-05-16 US US13/108,598 patent/US20110224212A1/en not_active Abandoned
-
2012
- 2012-01-12 US US13/349,222 patent/US8524709B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US8524709B2 (en) | 2013-09-03 |
CN101553482B (zh) | 2013-11-20 |
CA2662902A1 (en) | 2008-03-20 |
HK1133641A1 (zh) | 2010-04-01 |
JP2010503686A (ja) | 2010-02-04 |
CN101553482A (zh) | 2009-10-07 |
US20120115866A1 (en) | 2012-05-10 |
US20100261665A1 (en) | 2010-10-14 |
EP2079727A2 (en) | 2009-07-22 |
EP2079727A4 (en) | 2010-11-10 |
WO2008033562A3 (en) | 2008-08-21 |
WO2008033562A2 (en) | 2008-03-20 |
EP2079727B1 (en) | 2016-02-17 |
AU2007294686B2 (en) | 2013-10-31 |
KR101507375B1 (ko) | 2015-04-07 |
US7683057B2 (en) | 2010-03-23 |
CA2662902C (en) | 2015-11-24 |
AU2007294686A1 (en) | 2008-03-20 |
US8039470B2 (en) | 2011-10-18 |
ES2565683T3 (es) | 2016-04-06 |
JP5568304B2 (ja) | 2014-08-06 |
US20090076005A1 (en) | 2009-03-19 |
US20110224212A1 (en) | 2011-09-15 |
KR20090058563A (ko) | 2009-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1900033I1 (hu) | Szubsztituált enaminokarbonil vegyületek | |
HK1133641A1 (zh) | 激酶抑製劑化合物 | |
IL197381A0 (en) | Kinase inhibitor | |
HK1137295A1 (en) | Kinase inhibitor compounds | |
ZA200900109B (en) | Pyrrolotriazine kinase inhibitors | |
HK1114380A1 (en) | Pyrrolopyrazoles as kinase inhibitors | |
IL190078A0 (en) | Kinase inhibitors | |
ZA200808966B (en) | Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors | |
ZA200808599B (en) | 4-anilinoquinoline-3-carboxamides as CSF-1R kinase inhibitors | |
PL2402317T3 (pl) | Inhibitor DGAT | |
IL213464A0 (en) | Kinase inhibitor compounds | |
IL194356A0 (en) | Novel cyclobutyl compounds as kinase inhibitors | |
IL193482A0 (en) | Hydantoin based kinase inhibitors | |
HK1134674A1 (en) | Sulfoximines as kinase inhibitors | |
EP2166857A4 (en) | KINASE INHIBITOR COMPOUNDS | |
SI1943243T1 (sl) | Inhibotorji kinaz | |
EP2036893A4 (en) | ABL Kinase Inhibitor | |
GB0603522D0 (en) | Kinase inhibition | |
ZA200908943B (en) | Pyrazolopyrimidinone kinase inhibitor | |
IL197981A0 (en) | Kinase inhibitors | |
ZA200901570B (en) | Substituted azolin-2-YL-amino compounds | |
GB0608854D0 (en) | P13 kinase inhibitors | |
EP1998776A4 (en) | MACRO-HETEROCYL COMPOUNDS CONTAINING PYRIDINE AS KINASE INHIBITORS | |
EP1940411A4 (en) | MACROHETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | |
GB0606238D0 (en) | Kinase inhibition |